Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)

Trials. 2020 Jul 19;21(1):660. doi: 10.1186/s13063-020-04608-4.

Abstract

An amendment to this paper has been published and can be accessed via the original article.

Publication types

  • Published Erratum